Cancer
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
Research
November 21, 2019
Cardiovascular
November 20, 2019
Cardiovascular
November 20, 2019
Featured News
November 19, 2019
Featured News
November 18, 2019
Arizona
November 18, 2019
Cardiovascular
November 16, 2019
Biotherapeutics
November 16, 2019
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community